Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease

Jacob Tveiten Bjerrum, Casper Steenholdt, Mark Ainsworth, Ole Haagenb Nielsen, Michelle Thompson, Karen Atkins, Ulrich Gunther, Fuhua Hao, Yulan Wang

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)
194 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease'. Together they form a unique fingerprint.

Medicine & Life Sciences